AGRX - Agile Therapeutics, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD

Agile Therapeutics, Inc.

101 Poor Farm Road
Princeton, NJ 08540
United States
609-683-1880
http://www.agiletherapeutics.com

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Full Time Employees13

Key Executives

NameTitlePayExercisedYear Born
Mr. Alfred F. AltomariChairman & CEON/AN/A1959
Mr. Scott M. CoianteCFO & Sr. VPN/AN/A1967
Dr. Elizabeth Ijeoma Onyemelukwe GarnerSr. VP & Chief Medical OfficerN/AN/A1968
Mr. Geoffrey P. GilmoreGen. CounselN/AN/A1966
Mr. Robert G. ConwaySr. VP of Enterprise Planning & Information ManagementN/AN/A1957
Amounts are as of December 31, 2017 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Agile Therapeutics, Inc., a women's healthcare company, focuses on the development and commercialization of prescription contraceptive products for women. Its lead product candidate is Twirla, also known as AG200-15, a once-weekly prescription combination hormonal contraceptive patch, which completed Phase III clinical trials. The company is also developing a pipeline of other transdermal contraceptive products, including AG200-ER, a regimen that allows a woman to extend the length of her cycle; AG200-SP, which is a regimen designed to provide shorter lighter periods; AG200-ER (SmP), a regimen to allow a woman to extend the length of her cycle, as well as experience shorter and lighter periods; and AG890, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. Agile Therapeutics, Inc. was founded in 1997 and is headquartered in Princeton, New Jersey.

Corporate Governance

Agile Therapeutics, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.